A partnership between Celltech and Access Pharmaceuticals is
focusing on the use of a vitamin-based delivery technology for
monoclonal antibodies and antibody fragments.
Waters has launched a new MALDI-TOF (time of flight) mass
spectrometer, along with a line of porous silicon-coated target
plates and new reference standards,
Sidec Technologies has entered into a contract research
collaboration with a US research institute to study a receptor
involved in the regulation of blood pressure.
The lead compound in Merck and Karo Bio's selective oestrogen
receptor modulator collaboration has been dropped after toxicity
emerged preclinical tests.
Agilent launches two new products at the ongoing Drug Discovery
Technology meeting, including an LC column to remove high-abundance
proteins from serum and an oligonucleotide mouse microarray to aid
in toxicogenomics research.
Amersham trims its 2003 profit outlook again after reporting lower
interim sales and profits, but points to currency effects and the
underlying strength of the business
Amersham trimmed its 2003 profit forecast by £40 million (€57m), or
4.1 pence per share, after reporting lower sales and pre-tax
profits for the first half of 2003.
